Related Experiment Video

Updated: Jul 7, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Empiric antibiotic prescribing for patients with community-acquired pneumonia: where can we improve?

K L Buising1, K A Thursky, J F Black

  • 1Victorian Infectious Diseases Service, The Royal melbourne Hospital, Melbourne, Victoria, Australia. kirsty.buising@mh.org.au

Internal Medicine Journal
|February 23, 2008
PubMed
Abstract

Insights

Antibiotic prescribing for community-acquired pneumonia in Australia shows gaps in coverage for typical and atypical pathogens, and a concerning rate of prescribing to allergic patients. Improving early identification of severe illness and allergy recognition is crucial.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Public Health

Background:

  • Community-acquired pneumonia (CAP) is a frequent reason for antibiotic prescription in Australia.
  • Antibiotic stewardship is critical for managing CAP effectively and preventing resistance.

Purpose of the Study:

  • To audit empiric antibiotic prescribing practices for adults with CAP.
  • To identify areas for improvement in antibiotic selection and administration.

Main Methods:

  • A retrospective audit of 392 adult patients diagnosed with CAP.
  • Review of antibiotic prescribing records, including coverage for typical/atypical pathogens and documented allergies.

Main Results:

  • Only 61.9% of patients received adequate empiric antibiotic coverage for both typical and atypical pathogens.
  • 34.6% of intensive care unit (ICU) patients did not receive atypical pathogen cover within 24 hours.
  • 21.9% of patients with documented antibiotic allergies were prescribed antibiotics to which they were allergic.

Conclusions:

  • Prescribing practices for CAP require improvement, particularly regarding broad-spectrum coverage and allergy documentation.
  • Early identification of severe CAP and robust allergy recognition systems are essential.
  • Enhanced antibiotic stewardship programs can optimize CAP management and patient safety.

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.